Exosomal microRNA-155 as a biomarker for hepatic fibrosis diagnosis and progression

BACKGROUND: Pathological examination of liver biopsies remains the gold standard for evaluating the stage of hepatic fibrosis, which are a number of disadvantages associated with biopsy. The aim of the present study was to investigate the potential of exosomal microRNA (miR)-155 as a non-invasive bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Lian-Jie, Zhang, Ya-Min, Huang, Tao, Sun, Xian-Fu, Luo, Su-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867899/
https://www.ncbi.nlm.nih.gov/pubmed/33569439
http://dx.doi.org/10.21037/atm-20-7787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867899/
https://www.ncbi.nlm.nih.gov/pubmed/33569439
http://dx.doi.org/10.21037/atm-20-7787

Ejemplares similares